Assignee
ELLIPSES PHARMA LTD
GB·3 granted patents·7 pending applications·2 citations·filing 2018–2023
Top patents by PatentIndex Score
10 records- 0183US11771682B2AR+ breast cancer treatment methodsELLIPSES PHARMA LTD·Filed 2019·Granted Oct 3, 2023·2 cites·13 claims
- 0280US12329746B2AR+breast cancer treatment methodsELLIPSES PHARMA LTD·Filed 2023·Granted Jun 17, 2025·0 cites·26 claims
- 0376US2022409612A1Treatment of cancerELLIPSES PHARMA LTD·Filed 2022·Application pending·0 cites
- 0466US2020316212A1Methods of treating cancer using compounds containing a vascular disrupting agentELLIPSES PHARMA LTD·Filed 2020·Application pending·0 cites
- 0563US10912839B2Methods of treating cancer using compounds containing a vascular disrupting agentELLIPSES PHARMA LTD·Filed 2018·Granted Feb 9, 2021·0 cites·25 claims
- 0661US2021060003A1Treatment of cancerELLIPSES PHARMA LTD·Filed 2020·Application pending·0 cites
- 0760US2020375978A1Treatment of cancerELLIPSES PHARMA LTD·Filed 2020·Application pending·0 cites
- 0848US2023090337A1Pharmaceutical formulations comprising 6-chloro-7-(4-(4-chlorobenzyl)piperazin-1 -yl)-2-(1,3-dimethyl-1 hpyrazol-4-yl)-3h- imidazo[4,5-b]pyridineELLIPSES PHARMA LTD·Filed 2021·Application pending·0 cites
- 0947US2023285576A1Treatment of cancer using a cyclodextrin-containing polymer-topoisomerase inhibitor conjugate and a parp inhibitorELLIPSES PHARMA LTD·Filed 2021·Application pending·0 cites
- 1045US2023105181A1Salts and polymorphic forms of 6-chloro-7-(4-(4-chlorobenzyl)piperazin-1-yl)-2-(1,3-dimethyl-1h-pyrazol-4-yl)-3h-imidazo[4,5-b]pyridineELLIPSES PHARMA LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ELLIPSES PHARMA LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →